John D. Isaacs
Elite in Rheumatoid Arthritis (RA)

John D. Isaacs

Framlington Place, 
Newcastle Upon Tyne, ENG, GB 
Elite in Rheumatoid Arthritis (RA)
Framlington Place, 
Newcastle Upon Tyne, ENG, GB 
OverviewLocationsClinical Research

Overview

John Isaacs practices in Newcastle Upon Tyne, United Kingdom. Mr. Isaacs is rated as an Elite expert by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, Synovitis, and Endoscopy.

His clinical research consists of co-authoring 229 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 151 articles and participated in 2 clinical trials in the study of Rheumatoid Arthritis (RA).

Gender
Male

Locations

Framlington Place, Newcastle Upon Tyne, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Phase 1 Study of Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis
Phase 1 Study of Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: November 30, 2023
Intervention Type: Drug
Study Drugs: Tolerogenic Dendritic Cells, Arthroscopy & Saline Irrigation Alone
Study Phase: Phase 1
Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
Enrollment Status: Completed
Publish Date: November 06, 2017
Intervention Type: Drug
Study Phase: Not Applicable
View 2 Less Clinical Trials

226 Total Publications

Early onset neutropenia in rituximab treated rheumatoid arthritis patients: a case series.
Early onset neutropenia in rituximab treated rheumatoid arthritis patients: a case series.
Journal: Rheumatology advances in practice
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Isaacs's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile